Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human ERAB ELISA Kit (AC3951)
Cat.#: ASET-2540
Specifications
Description Human ERAB ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ERAB concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.19 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1288 Human Somatostatin Receptor 2 ELISA Kit (AC2699) Quantitative inquiry ASET-2122 Human COMT ELISA Kit (AC3533) Quantitative inquiry ASET-1658 ACTH ELISA Kit (AC3069) Quantitative inquiry ASET-1424 Human Semaphorin 3F ELISA Kit (AC2835) Quantitative inquiry ASET-2359 Mouse IL-6 ELISA Kit (AC3770) Quantitative inquiry ASET-1797 Rabbit Fetuin A ELISA Kit (AC3208) Quantitative inquiry ASET-1491 Human Artemin ELISA Kit (AC2902) Quantitative inquiry ASET-1419 Chicken LIF ELISA Kit (AC2830) Quantitative inquiry ASET-1193 Human SPON2 ELISA Kit (AC2604) Quantitative inquiry ASET-1469 Mouse Choline Acetyltransferase ELISA Kit (AC2880) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket